Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
Baranca Buijsers, Cansu Yanginlar, Marissa L. Maciej-Hulme, et al.
EBioMedicine (2020) Vol. 59, pp. 102969-102969
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Patrick R. Lawler, Ewan C. Goligher, Jeffrey S. Berger, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 9, pp. 790-802
Open Access | Times Cited: 555
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, et al.
The Lancet (2021) Vol. 397, Iss. 10291, pp. 2253-2263
Open Access | Times Cited: 452
Patients with COVID-19: in the dark-NETs of neutrophils
Maximilian Ackermann, Hans‐Joachim Anders, Rostyslav Bilyy, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 11, pp. 3125-3139
Open Access | Times Cited: 256
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
Larissa E. van Eijk, Mathijs Binkhorst, Arno R. Bourgonje, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 307-331
Open Access | Times Cited: 124
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
Parastoo Tarighi, S. Eftekhari, Milad Chizari, et al.
European Journal of Pharmacology (2021) Vol. 895, pp. 173890-173890
Open Access | Times Cited: 116
Increased Plasma Heparanase Activity in COVID-19 Patients
Baranca Buijsers, Cansu Yanginlar, Aline de Nooijer, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 121
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 9, pp. 1801-1814
Open Access | Times Cited: 100
The cytokine storm and thyroid hormone changes in COVID-19
Laura Croce, Dave Gangemi, Giuseppe Ancona, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 5, pp. 891-904
Open Access | Times Cited: 91
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Marcel Levi, Toshiaki Iba
Internal and Emergency Medicine (2020) Vol. 16, Iss. 2, pp. 309-312
Open Access | Times Cited: 89
Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets
Yupei Li, Dingyuan Wan, Xinyao Luo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 74
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6574-6574
Open Access | Times Cited: 61
Potential relationships between COVID-19 and the thyroid gland: an update
Rania Naguib
Journal of International Medical Research (2022) Vol. 50, Iss. 2
Open Access | Times Cited: 60
Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation
Marion Pilard, Estelle L. Ollivier, Virginie Gourdou-Latyszenok, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 41
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia
Jean‐Louis Vincent, Marcel Levi, Beverley J. Hunt
The Lancet Respiratory Medicine (2021) Vol. 10, Iss. 2, pp. 214-220
Open Access | Times Cited: 45
Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis
Michelle Sholzberg, Bruno R. da Costa, Grace H. Tang, et al.
Research and Practice in Thrombosis and Haemostasis (2021) Vol. 5, Iss. 8, pp. e12638-e12638
Open Access | Times Cited: 44
The Alterations and Roles of Glycosaminoglycans in Human Diseases
Qingchi Wang, Lianli Chi
Polymers (2022) Vol. 14, Iss. 22, pp. 5014-5014
Open Access | Times Cited: 35
Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19
Duoduo Zha, Mingui Fu, Yisong Qian
Cells (2022) Vol. 11, Iss. 12, pp. 1972-1972
Open Access | Times Cited: 33
Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Aijia Wu, Kunyu Shi, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115923-115923
Closed Access | Times Cited: 17
Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections
Brayan J. Anaya, Davide D’Angelo, Ruggero Bettini, et al.
Carbohydrate Polymers (2024) Vol. 348, pp. 122930-122930
Closed Access | Times Cited: 7
Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle
Tima Dehghani, Alyssa Panitch
Open Biology (2020) Vol. 10, Iss. 10
Open Access | Times Cited: 46
The interplay between neutrophils, complement, and microthrombi in COVID-19
Yu Zuo, Yogendra Kanthi, Jason S. Knight, et al.
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 1, pp. 101661-101661
Open Access | Times Cited: 38
Therapeutic strategies to fight COVID‐19: Which is the status artis?
Cristina Scavone, Annamaria Mascolo, Concetta Rafaniello, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 10, pp. 2128-2148
Open Access | Times Cited: 37
Lung histopathological findings in COVID-19 disease – a systematic review
Giuseppe Pannone, Vito Carlo Alberto Caponio, Ilenia Sara De Stefano, et al.
Infectious Agents and Cancer (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 37
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
Halie M. Rando, Adam L. MacLean, Alexandra Lee, et al.
mSystems (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top